Accuvest Global Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-15,938
Closed -$529K 119
2023
Q3
$529K Buy
15,938
+2,698
+20% +$95.4K 0.29% 62
2023
Q2
$486K Buy
13,240
+3,520
+36% +$137K 0.25% 78
2023
Q1
$397K Sell
9,720
-16,234
-63% -$701K 0.18% 84
2022
Q4
$1.33M Buy
25,954
+12,960
+100% +$621K 0.44% 51
2022
Q3
$569K Buy
12,994
+1,848
+17% +$89.8K 0.39% 54
2022
Q2
$584K Sell
11,146
-690
-6% -$35.2K 0.38% 54
2022
Q1
$613K Buy
11,836
+1,395
+13% +$72.4K 0.31% 61
2021
Q4
$617K Buy
10,441
+905
+9% +$44.8K 0.27% 61
2021
Q3
$410K Buy
9,536
+517
+6% +$22.9K 0.19% 73
2021
Q2
$353K Buy
9,019
+1,615
+22% +$62.8K 0.18% 69
2021
Q1
$268K Buy
+7,404
New +$263K 0.14% 79
2020
Q2
Sell
-346
Closed -$11K 59
2020
Q1
$11K Buy
+346
New +$11.8K 0.03% 40
2019
Q1
Sell
-27,267
Closed -$1.13M 127
2018
Q4
$1.13M Buy
27,267
+1,946
+8% +$80.8K 0.59% 33
2018
Q3
$1.06M Buy
25,321
+14,145
+127% +$545K 0.39% 43
2018
Q2
$385K Buy
11,176
+11,012
+6,715% +$376K 0.15% 104
2018
Q1
$6K Hold
164
﹤0.01% 85
2017
Q4
$6K Hold
164
﹤0.01% 75
2017
Q3
$6K Sell
164
-16,635
-99% -$535K 0.01% 61
2017
Q2
$535K Buy
+16,799
New +$530K 0.18% 56
2015
Q1
Sell
-16,421
Closed -$485K 86
2014
Q4
$485K Buy
+16,421
New +$471K 0.1% 80

Other funds holding PFE

Accuvest Global Advisors's PFE Position: Q4 2023 in Review

Accuvest Global Advisors sold out of Pfizer (PFE) in Q4 2023, closing a stake of 15,938 shares — an estimated $529K sold.

Accuvest Global Advisors first reported a position in PFE in Q4 2014 and held it in 20 quarters. The position peaked at $1.33M in Q4 2022. 2,940 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

  • Accuvest Global Advisors reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
  • Accuvest Global Advisors sold 15,938 Pfizer shares in Q4 2023, an estimated $529K.
  • Accuvest Global Advisors first reported a position in Pfizer in Q4 2014 and held it in 20 quarters.
  • Accuvest Global Advisors's Pfizer position peaked at $1.33M in Q4 2022.
  • 2,940 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Accuvest Global Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.